-2.6 | | U5 | 'MCC950; 10 microgram per milliliter' vs 'none' | compound | RNA-seq of mouse sciatic peripheral nerve of injured mouse with implant: control (untreated) vs local delivery of MCC950 (NLRP3inh) vs standard FBR treatment dexamethasone (Dex). . |
-2.2 | | U5 | 'dexamethasone; 10 microgram per milliliter' vs 'none' | compound | RNA-seq of mouse sciatic peripheral nerve of injured mouse with implant: control (untreated) vs local delivery of MCC950 (NLRP3inh) vs standard FBR treatment dexamethasone (Dex). . |
-1.9 | | U5 | 'wild type; treated with angiotensin II and a combination of hydralazine and hydrochlorothiazide' vs 'wild type; vehicle' | genotype, treatment | Effect of Hypertension of Dendritic Cell Gene Expression |
1.7 | | U5 | 'Mdr2-knockout' vs 'wild type' | genotype | Gene Expression Data for female C57BL/6, Mdr2-KO and Mdr2-KO/IL6-KO at the age of 14 months |
-1.7 | | U5 | "acute exposure to downstream water" vs "acute exposure to control water" | environmental history, generation | Toxicogenomic analysis in liver of mice exposed to polluted groundwater |
-1.6 | | U5 | "acute exposure to upstream water" vs "acute exposure to control water" | environmental history, generation | Toxicogenomic analysis in liver of mice exposed to polluted groundwater |
1.6 | | U5 | 'lamina propria' vs 'bone marrow' | organism part | Comparison of gene expression profile in RAG2+ B lineage cells from the small intestinal lamina propria and RAG2+ B lineage cells from the bone marrow |
-1.4 | | U5 | 'CXCR4 overexpression' vs 'wild type' | phenotype | Transcription profiling by array of resting memory OT-I T_CXCR4 or OT-I T_Control cells isolated from the spleen 90 days following DC vaccination |
-1.2 | | U5 | 'miR-1-133a_FGFR1_tKO' vs 'miR-1-133a_dKO' | compound, genotype | Repression of OSMR and FGFR1 by miR-1/133a prevents adult cardiomyocyte dedifferentiation and cell cycle entry in the adult heart |
1 | | U5 | 'pre-B acute lymphoblastic leukemia 8093; nilotinib; 3 day' vs 'pre-B acute lymphoblastic leukemia 8093; nilotinib; 0 day' | cell type, compound, time | Drug tolerance development of mouse Bcr/Abl pre-B ALL cells on irradiated MEFs |
1 | | U5 | 'one year after pulmonary macrophage transplantation; Csf2rb-/-' vs 'untreated; Csf2rb-/-' | clinical history, genotype | Mouse GM-CSF-related alveolar macrophage genome-wide expression data |